title: [Inhibition of neutrophil-derived IL-8 production caused by EM (erythromycin) 201 derivative: modification of the activities by the 5-position desosamine side chain].
authors.forename: H
authors.initials: H
authors.lastname: Yoshimine
authors.forename: K
authors.initials: K
authors.lastname: Oishi
authors.forename: T
authors.initials: T
authors.lastname: Nagatake
authors.forename: K
authors.initials: K
authors.lastname: Matsushima
authors.forename: T
authors.initials: T
authors.lastname: Omura
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002478:Cells, Cultured; D017291:Clarithromycin / Q000494:pharmacology; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D016209:Interleukin-8 / Q000096:biosynthesis*; D009504:Neutrophils / Q000276:immunology*; D013329:Structure-Activity Relationship
chemical_list: D000900:Anti-Bacterial Agents; D016209:Interleukin-8; C093673:8,9-anhydroerythromycin A 6,9-hemiketal; D004917:Erythromycin; D017291:Clarithromycin